Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @amicusrx1
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @amicusrx1
-
Prikvačeni tweet
America’s biopharmaceutical industry has lost the trust of many of our patients. We’re committed to reversing this trend by pledging a new Commitment to Patients and the Public:https://www.linkedin.com/pulse/new-commitment-patients-john-f-crowley/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Many business practices of the biopharmaceutical industry are simply unacceptable when the public health is at stake. Many practices do not put patients first. This must change - and we must be the agents of that change.https://www.realclearhealth.com/articles/2020/01/30/pharma_industry_lost_your_trust_heres_how_200_leaders_want_to_earn_it_back_110983.html …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amicus is proud to support the
@BioNJ_Org 2020 Annual Dinner Meeting & Innovation Celebration. We will be there and hope to see you on February 6. For more information, visit http://www.BioNJ.org !pic.twitter.com/d55aPuNbYY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ICYMI: A full replay of today’s 3Q19#FinancialResults conference call and webcast can be accessed via the Investor Relations section our website.$FOLD#Q3Results#RareCompanyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tune in now to our 3Q19
#FinancialResults conference call and webcast.$FOLD#Q3ResultsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Amicus Therapeutics at 8:30 a.m. ET for our 3Q19
#FinancialResults conference call and webcast.$FOLD#Q3ResultsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This morning, we announced our 3Q19
#FinancialResults and corporate updates. Live conference call and webcast this morning at 8:30 a.m. ET$FOLD#RareCompany#Q3ResultsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amicus Therapeutics proslijedio/la je Tweet
A standing ovation for the inspiration speech from John Crowley, Chairman and CEO, Co-Founder, Amicus Therapeutics, at the 2019
#ISPE Annual Meeting & Expo, where he was a keynote speaker speaking about when drug research is personal.#ISPEAM19pic.twitter.com/OKkXkKJRQXHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ICYMI: A full audio webcast replay of today’s#AmicusAnalystDay can be accessed via the Investors Relations page of the Amicus corporate website.$FOLD#RareCompanyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As
#AmicusAnalystDay comes to a close, we will continue to advance our vision to create significant value for patients and shareholders#RareCompanypic.twitter.com/rCtyUSGKDZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. James Wilson presents an overview of the Amicus-
@PennMedBench collaboration and next generation research program to drive the second wave of innovation for#GeneTherapypic.twitter.com/kHqsgXlZZ6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Chief Science Officer Hung Do describes our natural evolution from pharmacological chaperones to next-generation ERTs to
#genetherapy.#AmicusAnalystDay$FOLD https://edge.media-server.com/mmc/p/macsserd pic.twitter.com/CRYmTEDIRf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Chief Medical Officer Jay Barth is discussing our latest clinical data for AT-GAA in
#Pompe disease.#AmicusAnalystDay$FOLD https://edge.media-server.com/mmc/p/macsserd pic.twitter.com/rfMiCCnJHG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We have had several opportunities to deliver significant value for shareholders and patients.
#AmicusAnalystDay$FOLD https://edge.media-server.com/mmc/p/macsserd pic.twitter.com/2WzCqCluE1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our chairman & CEO John F. Crowley kicks off the
#AmicusAnalystDay by sharing a few words on our vision, mission and strategy. Tune in now! http://edge.media-server.com/mmc/p/macsserd pic.twitter.com/SVfXK2j0r0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, the Amicus team will host an Analyst Day in NYC. Tune in to learn more about the Company’s vision and leadership in discovering, developing and delivering medicines for people living with rare diseases. Live webcast today at 8:30 a.m. ET.
$FOLDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amicus announces corporate updates and highlights for
#AmicusAnalystDayHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Chairman and CEO, John F. Crowley, will be discussing the importance of a patient-dedicated company culture during his keynote session at the 17th
#CCGF. Learn more at: http://bit.ly/2xTv0Jv .Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amicus Chairman & CEO, John F. Crowley presenting at the Cantor Fitzgerald Global Healthcare Conference today in NYC.
$FOLD#RareCompanypic.twitter.com/QXCYEcl1nr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$FOLD will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference in New York City on Wednesday, October 2 at 8:20 a.m. ETHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.